查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496168

全球治療藥物市場（2024年版）：按分子類型、治療領域、地區和國家分類的分析、市場考慮和預測（2020-2030年）

Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
出版日期: | 出版商: Azoth Analytics | 英文 224 Pages | 訂單完成後即時交付

價格

2020年至2023年，全球治療藥物市場規模年複合成長率為6.61%。2023年市場規模為6869.7億美元，2030年預計將達到11159億美元。

癌症、心臟病、糖尿病和神經病變等慢性疾病推動市場發展。根據世界衛生組織（WHO）的報告，這些疾病是導致死亡和殘疾的主要原因，佔所有死亡的70%以上。該成長是由於人口老化、不健康的生活方式和環境污染等因素造成的。

此外，預計到2050年，60歲及以上人口將達到20億，人口迅速老化，阿茲海默症、失智症、骨質疏鬆症等與老齡化相關的疾病日益普遍，治療需求日益增加。此外，老年人更容易患多種慢性疾病，因此需要開發聯合治療和有效的管理策略。

展望未來，由於技術創新、個人化醫療以及對成本效益的日益關注，全球治療市場預計將繼續成長，為市場參與企業創造新的機會。此外，抗生素抗藥性日益嚴重的威脅強烈表明需要新的抗菌療法。

本報告調查全球治療藥物市場，並提供了包括市場規模和預測、區域和細分市場分析以及主要趨勢和機會的資訊。

目錄

第1章 市場背景

  • 產品範圍和產品前景
  • 執行摘要
  • 調查方法

第2章 分析師建議

  • 個人化醫療
  • 奈米醫學標靶治療

第3章 全球治療​​藥物市場：實績與預測

  • 宏觀經濟因素對治療藥物市場的影響分析
  • 全球生物技術支出
  • 歐洲、美國、日本和中國的醫藥研發支出
  • 有效 API DMF 總數：依國家分類
  • 最省錢的 10 種非專利產品（2022）
  • 全球治療藥物市場：儀表板
  • 全球治療藥物市場：市場規模與年複合成長率（2020-2030）
  • 全球治療藥物市場：市場金額評估
  • 評估 COVID-19 對治療藥物市場的影響
  • 全球治療藥物市場細分：按分子類型
    • 全球治療藥物市場：按分子類型概述
    • 全球治療藥物市場吸引力指數：依分子類型
    • 全球治療藥物市場規模：生技藥品、生物相似藥（金額）（2020-2030）
    • 全球治療藥物市場規模：小分子（金額）（2020-2030）
  • 全球治療方法市場細分：依治療領域
    • 全球治療藥物市場：依治療領域概述
    • 全球治療藥物市場吸引力指數：依治療領域
    • 全球治療藥物市場規模：腫瘤（金額）（2020-2030）
    • 全球治療藥物市場規模：感染疾病（金額）（2020-2030）
    • 全球治療藥物市場規模：心血管疾病（金額）（2020-2030）
    • 全球治療藥物市場規模：糖尿病/肥胖（金額）（2020-2030）
    • 全球治療藥物市場規模：免疫學（金額）（2020-2030）
    • 全球治療藥物市場規模：其他治療領域（金額）（2020-2030）

第4章 全球治療藥物市場、區域分析

  • 研究的區域範圍
  • 區域簡介

第5章 北美與南美治療藥物市場：實績與預測

  • 美洲治療市場：簡介
  • 美洲治療藥物市場：市場規模與年複合成長率（2020-2030）
  • 美洲治療藥物市場：主要因素
  • 美洲治療藥物市場：細分分析
  • 美洲治療藥物市場細分：依分子類型
  • 美洲治療藥物市場細分：治療領域
  • 美洲治療藥物市場細分：依國家
    • 美洲治療藥物市場：依國家分類，概述
    • 美國治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 加拿大治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 其他美洲治療藥物市場：市場規模和年複合成長率（2020-2030）

第6章 歐洲治療藥物市場：實績與預測

  • 歐洲治療市場：概況
  • 歐洲治療藥物市場：市場規模與年複合成長率（2020-2030）
  • 歐洲治療藥物市場：主要因素
  • 歐洲治療藥物市場：細分分析
  • 歐洲治療藥物市場細分：按分子類型
  • 歐洲治療藥物市場細分：依治療領域
  • 歐洲治療藥物市場細分：依國家/地區
    • 歐洲治療藥物市場：依國家分類，概述
    • 德國治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 英國治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 法國治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 義大利治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 西班牙治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 其他歐洲治療藥物市場：市場規模和年複合成長率（2020-2030）

第7章 亞太治療藥物市場：實績與預測

  • 亞太治療市場：概況
  • 亞太地區治療藥物市場：市場規模與年複合成長率（2020-2030）
  • 亞太地區治療藥物市場：主要因素
  • 亞太地區治療藥物市場：細分分析
  • 亞太地區治療藥物市場細分：依分子類型
  • 亞太地區治療藥物市場細分：依治療領域
  • 亞太地區治療藥物市場細分：依國家
    • 亞太地區治療藥物市場：依國家分類，概述
    • 中國治療藥物市場：市場規模及年複合成長率（2020-2030）
    • 日本治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 印度治療藥物市場：市場規模與年複合成長率（2020-2030）
    • 亞太地區其他治療藥物市場：市場規模與年複合成長率（2020-2030）

第8章 中東和非洲的治療藥物市場：實際結果和預測

  • 中東和非洲治療藥物市場：簡介
  • 中東和非洲治療藥物市場：市場規模和年複合成長率（2020-2030）
  • 中東和非洲治療藥物市場：主要因素
  • 中東和非洲治療藥物市場：細分分析
  • 中東和非洲治療藥物市場細分：按分子類型
  • 中東和非洲治療藥物市場細分：依治療領域

第9章 市場動態

  • 評估市場動態對治療藥物市場的影響
  • 促進因素
  • 抑制因素
  • 趨勢

第10章 產業生態系分析

  • 波特分析

第11章 競爭定位

  • 企業產品定位
  • 市場地位矩陣
  • 治療藥物市場市場佔有率分析
  • 公司簡介
    • Sanofi
    • Cipla
    • Pfizer
    • GSK PLC
    • Novartis AG
    • Bayer AG
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Gilead Sciences, Inc.

第12章 關於公司、免責聲明

Executive Summary

Azoth Analytics has released a research report titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, Cardiovascular Disease, Diabetes/Obesity, Immunology, Other Therapeutic Areas) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Therapeutics market showcased growth at a CAGR of 6.61% during 2020-2023. The market was valued at USD 686.97 Billion in 2023 which is expected to reach USD 1115.90 Billion in 2030.

Chronic diseases like cancer, heart disease, diabetes, and neurological disorders are fueling the global therapeutics market. The World Health Organization (WHO) reports these conditions as the leading cause of death and disability, accounting for over 70% of all deaths. This rise is attributed to factors like an aging population, unhealthy lifestyles, and environmental pollution.

Furthermore, the rapidly aging population, with the number of people over 60 expected to reach 2 billion by 2050, creates a growing demand for treatments for age-related conditions like Alzheimer's, dementia, and osteoporosis. Additionally, the elderly are more prone to multiple chronic conditions, necessitating the development of combination therapies and effective management strategies.

Looking ahead, the global therapeutics market is poised for continued growth due to the increasing focus on innovation, personalized medicine, and cost-effectiveness, creating new opportunities for market players. Additionally, the growing threat of antibiotic resistance underscores the need for novel antimicrobial therapies.

Scope of the Report:

  • The report analyses the Therapeutics Market by Value (USD Billion).
  • The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report presents the analysis of Therapeutics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Therapeutics Market By Molecule Type (Biologics and Biosimilars, Small Molecules)
  • The report analyses the Therapeutics Market By Therapeutic Area (Oncology, Infectious Disease, and Cardiovascular Disease, Diabetes/Obesity, Immunology, and Other Therapeutic Areas).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Molecule Type and By Therapeutic Areas.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Analyst Recommendations

  • 2.1 Personalized Medicine
  • 2.2 Targeted therapy with Nanomedicine

3. Global Therapeutics Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Therapeutics Market
  • 3.2 Global biotech spending
  • 3.3 Pharmaceutical R&D expenditure in Europe, USA, Japan and China
  • 3.4 Total Active API DMFs, by country
  • 3.5 Top 10 Generic Products with Greatest Savings in 2022
  • 3.6 Global Therapeutics Market: Dashboard
  • 3.7 Global Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 3.8 Global Therapeutics Market: Market Value Assessment
  • 3.9 Assessment Degree of Impact of COVID-19 on Therapeutics Market
  • 3.10 Global Therapeutics Market Segmentation: By Molecule Type
    • 3.10.1 Global Therapeutics Market, By Molecule Type Overview
    • 3.10.2 Global Therapeutics Market Attractiveness Index, By Molecule Type
    • 3.10.3 Global Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.4 Global Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11 Global Therapeutics Market Segmentation: By Therapeutic Area
    • 3.11.1 Global Therapeutics Market, By Therapeutic Area Overview
    • 3.11.2 Global Therapeutics Market Attractiveness Index, By Therapeutic Area
    • 3.11.3 Global Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.4 Global Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.5 Global Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.6 Global Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.7 Global Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.11.8 Global Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Therapeutics Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Therapeutics Market: Historic and Forecast

  • 5.1 Americas Therapeutics Market: Snapshot
  • 5.2 Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 5.3 Americas Therapeutics Market: Key Factors
  • 5.4 Americas Therapeutics Market: Segment Analysis
  • 5.5 Americas Therapeutics Market Segmentation: By Molecule Type
    • 5.5.1 Americas Therapeutics Market, By Molecule Type Overview
    • 5.5.2 Americas Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.3 Americas Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6 Americas Therapeutics Market Segmentation: Therapeutic Area
    • 5.6.1 Americas Therapeutics Market, By Therapeutic Area Overview
    • 5.6.2 Americas Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.3 Americas Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.4 Americas Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.5 Americas Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.6 Americas Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.7 Americas Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7 Americas Therapeutics Market Segmentation: By Country
    • 5.7.1 Americas Therapeutics Market, by Country Overview
    • 5.7.2 United States Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.2.1 United States Therapeutics Market, By Molecule Type
      • 5.7.2.2 United States Therapeutics Market, By Therapeutic Area
    • 5.7.3 Canada Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.3.1 Canada Therapeutics Market, By Molecule Type
      • 5.7.3.2 Canada Therapeutics Market, By Therapeutic Area
    • 5.7.4 Rest of Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.7.4.1 Rest of Americas Therapeutics Market, By Molecule Type
      • 5.7.4.2 Rest of Americas Therapeutics Market, By Therapeutic Area

6. Europe Therapeutics Market: Historic and Forecast

  • 6.1 Europe Therapeutics Market: Snapshot
  • 6.2 Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 6.3 Europe Therapeutics Market: Key Factors
  • 6.4 Europe Therapeutics Market: Segment Analysis
  • 6.5 Europe Therapeutics Market Segmentation: By Molecule Type
    • 6.5.1 Europe Therapeutics Market, By Molecule Type Overview
    • 6.5.2 Europe Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.3 Europe Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6 Europe Therapeutics Market Segmentation: By Therapeutic Area
    • 6.6.1 Europe Therapeutics Market, By Therapeutic Area Overview
    • 6.6.2 Europe Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.4 Europe Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.5 Europe Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.6 Europe Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.7 Europe Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7 Europe Therapeutics Market Segmentation: By Country
    • 6.7.1 Europe Therapeutics Market, by Country Overview
    • 6.7.2 Germany Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.2.1 Germany Therapeutics Market, By Molecule Type
      • 6.7.2.2 Germany Therapeutics Market, By Therapeutic Area
    • 6.7.3 United Kingdom Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.3.1 United Kingdom Therapeutics Market, By Molecule Type
      • 6.7.3.2 United Kingdom Therapeutics Market, By Therapeutic Area
    • 6.7.4 France Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.4.1 France Therapeutics Market, By Molecule Type
      • 6.7.4.2 France Therapeutics Market, By Therapeutic Area
    • 6.7.5 Italy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.5.1 Italy Therapeutics Market, By Molecule Type
      • 6.7.5.2 Italy Therapeutics Market, By Therapeutic Area
    • 6.7.6 Spain Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.6.1 Spain Therapeutics Market, By Molecule Type
      • 6.7.6.2 Spain Therapeutics Market, By Therapeutic Area
    • 6.7.7 Rest of Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.7.7.1 Rest of Europe Therapeutics Market, By Molecule Type
      • 6.7.7.2 Rest of Europe Therapeutics Market, By Therapeutic Area

7. Asia Pacific Therapeutics Market: Historic and Forecast

  • 7.1 Asia Pacific Therapeutics Market: Snapshot
  • 7.2 Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 7.3 Asia Pacific Therapeutics Market: Key Factors
  • 7.4 Asia Pacific Therapeutics Market: Segment Analysis
  • 7.5 Asia Pacific Therapeutics Market Segmentation: By Molecule Type
    • 7.5.1 Asia Pacific Therapeutics Market, By Molecule Type Overview
    • 7.5.2 Asia Pacific Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.3 Asia Pacific Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6 Asia Pacific Therapeutics Market Segmentation: By Therapeutic Area
    • 7.6.1 Asia Pacific Therapeutics Market, By Therapeutic Area Overview
    • 7.6.2 Asia Pacific Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.4 Asia Pacific Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.5 Asia Pacific Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.6 Asia Pacific Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.7 Asia Pacific Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7 Asia Pacific Therapeutics Market Segmentation: By Country
    • 7.7.1 Asia Pacific Therapeutics Market, by Country Overview
    • 7.7.2 China Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.2.1 China Therapeutics Market, By Molecule Type
      • 7.7.2.2 China Therapeutics Market, By Therapeutic Area
    • 7.7.3 Japan Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.3.1 Japan Therapeutics Market, By Molecule Type
      • 7.7.3.2 Japan Therapeutics Market, By Therapeutic Area
    • 7.7.4 India Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.4.1 India Therapeutics Market, By Molecule Type
      • 7.7.4.2 India Therapeutics Market, By Therapeutic Area
    • 7.7.5 Rest of Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.7.5.1 Rest of Asia Pacific Therapeutics Market, By Molecule Type
      • 7.7.5.2 Rest of Asia Pacific Therapeutics Market, By Therapeutic Area

8. Middle East and Africa Therapeutics Market: Historic and Forecast

  • 8.1 Middle East and Africa Therapeutics Market: Snapshot
  • 8.2 Middle East and Africa Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 8.3 Middle East and Africa Therapeutics Market: Key Factors
  • 8.4 Middle East and Africa Therapeutics Market: Segment Analysis
  • 8.5 Middle East and Africa Therapeutics Market Segmentation: By Molecule Type
    • 8.5.1 Middle East and Africa Therapeutics Market, By Molecule Type Overview
    • 8.5.2 Middle East and Africa Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.3 Middle East and Africa Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6 Middle East and Africa Therapeutics Market Segmentation: By Therapeutic Area
    • 8.6.1 Middle East and Africa Therapeutics Market, By Therapeutic Area Overview
    • 8.6.2 Middle East and Africa Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.4 Middle East and Africa Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.5 Middle East and Africa Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.6 Middle East and Africa Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.7 Middle East and Africa Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Therapeutics Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Therapeutics Market
  • 11.4 Company Profiles
    • 11.4.1 Sanofi
    • 11.4.2 Cipla
    • 11.4.3 Pfizer
    • 11.4.4 GSK PLC
    • 11.4.5 Novartis AG
    • 11.4.6 Bayer AG
    • 11.4.7 Merck & Co., Inc.
    • 11.4.8 F. Hoffmann-La Roche AG
    • 11.4.9 Abbott Laboratories
    • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer

List of Figures

  • Figure 1: Global biotech spending
  • Figure 2: Pharmaceutical R&D expenditure in Europe, USA, Japan and China ( Million, 2020 constant exchange rate*)
  • Figure 3: Total Active API DMFs, by country, as of 2021
  • Figure 4: Global Therapeutics Market Size, By Value, 2020-2023 (USD Billion)
  • Figure 5: Global Therapeutics Market Size, By Value, 2024-2030 (USD Billion)
  • Figure 6: Global Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 7: Market Attractiveness Analysis of Therapeutics Market, By Molecule Type (2025-2030)
  • Figure 8: Global Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 9: Global Therapeutics Market Absolute Opportunity, By Biologics and Biosimilars, 2020-2030 (USD Billion)
  • Figure 10: Global Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 11: Global Therapeutics Market Absolute Opportunity, By Small Molecules, 2020-2030 (USD Billion)
  • Figure 12: Market Attractiveness Analysis of Therapeutics Market, By Therapeutic Area (2025-2030)
  • Figure 13: Global Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 14: Global Therapeutics Market Absolute Opportunity, By Oncology, 2020-2030 (USD Billion)
  • Figure 15: Global Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 16: Global Therapeutics Market Absolute Opportunity, By Infectious Disease, 2020-2030 (USD Billion)
  • Figure 17: Global Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 18: Global Therapeutics Market Absolute Opportunity, By Cardiovascular Disease, 2020-2030 (USD Billion)
  • Figure 19: Global Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 20: Global Therapeutics Market Absolute Opportunity, By Diabetes/Obesity, 2020-2030 (USD Billion)
  • Figure 21: Global Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 22: Global Therapeutics Market Absolute Opportunity, By Immunology, 2020-2030 (USD Billion)
  • Figure 23: Global Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 24: Global Therapeutics Market Absolute Opportunity, By Other Therapeutic Areas, 2020-2030 (USD Billion)
  • Figure 25: Americas Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 26: Americas Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 27: Americas Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 28: Americas Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 29: Americas Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 30: Americas Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 31: Americas Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 32: Americas Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 33: Americas Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 34: Americas Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 35: United States Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 36: United States Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 37: United States Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 38: United States Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 39: Canada Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 40: Canada Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 41: Canada Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 42: Canada Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 43: Rest of Americas Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 44: Rest of Americas Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 45: Rest of Americas Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 46: Rest of Americas Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 47: Europe Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 48: Europe Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 49: Europe Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 50: Europe Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 51: Europe Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 52: Europe Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 53: Europe Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 54: Europe Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 55: Europe Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 56: Europe Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 57: Germany Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 58: Germany Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 59: Germany Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 60: Germany Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 61: United Kingdom Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 62: United Kingdom Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 63: United Kingdom Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 64: United Kingdom Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 65: France Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 66: France Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 67: France Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 68: France Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 69: Italy Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 70: Italy Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 71: Italy Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 72: Italy Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 73: Spain Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 74: Spain Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 75: Spain Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 76: Spain Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 77: Rest of Europe Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 78: Rest of Europe Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 79: Rest of Europe Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 80: Rest of Europe Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 81: Asia Pacific Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 82: Asia Pacific Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 83: Asia Pacific Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 84: Asia Pacific Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 85: Asia Pacific Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 86: Asia Pacific Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 87: Asia Pacific Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 88: Asia Pacific Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 89: Asia Pacific Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 90: Asia Pacific Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 91: China Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 92: China Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 93: China Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 94: China Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 95: Japan Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 96: Japan Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 97: Japan Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 98: Japan Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 99: India Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 100: India Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 101: India Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 102: India Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 103: Rest of Asia Pacific Therapeutics Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 104: Rest of Asia Pacific Therapeutics Market Value, By Molecule Type, 2023 (USD Billion)
  • Figure 105: Rest of Asia Pacific Therapeutics Market Share, By Molecule Type, By Value, 2023 (%)
  • Figure 106: Rest of Asia Pacific Therapeutics Market Share, By Therapeutic Area, By Value, 2023 (%)
  • Figure 107: Middle East and Africa Therapeutics Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 108: Middle East and Africa Therapeutics Market Share, By Therapeutic Areas, 2023 (%)
  • Figure 109: Middle East and Africa Therapeutics Market, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 110: Middle East and Africa Therapeutics Market, By Small Molecules, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 111: Middle East and Africa Therapeutics Market, By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 112: Middle East and Africa Therapeutics Market, By Infectious Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 113: Middle East and Africa Therapeutics Market, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 114: Middle East and Africa Therapeutics Market, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 115: Middle East and Africa Therapeutics Market, By Immunology, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 116: Middle East and Africa Therapeutics Market, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 117: Market Share of Prominent Companies of Therapeutics Market, 2023 (%)
  • Figure 118: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 119: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 120: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 121: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 122: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 123: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 124: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 125: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 126: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 127: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 128: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 129: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 130: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 131: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 132: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 133: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 135: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 121: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 122: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 123: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 124: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 125: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 126: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 127: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 128: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 129: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 130: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 131: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 132: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 133: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 135: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Top 10 Generic Products with Greatest Savings in 2022

Table A3: United States Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A4: United States Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A5: United States Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A6: United States Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A7: Canada Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A8: Canada Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A9: Canada Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A10: Canada Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A11: Rest of Americas Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A12: Rest of Americas Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A13: Rest of Americas Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A14: Rest of Americas Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A15: Germany Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A16: Germany Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A17: Germany Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A18: Germany Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A19: United Kingdom Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A20: United Kingdom Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A21: United Kingdom Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A22: United Kingdom Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A23: France Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A24: France Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A25: France Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A26: France Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A27: Italy Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A28: Italy Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A29: Italy Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A30: Italy Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A31: Spain Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A32: Spain Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A33: Spain Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A34: Spain Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A35: Rest of Europe Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A36: Rest of Europe Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A37: Rest of Europe Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A38: Rest of Europe Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A39: China Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A40: China Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A41: China Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A42: China Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A43: Japan Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A44: Japan Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A45: Japan Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A46: Japan Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A47: India Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A48: India Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A49: India Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A50: India Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A51: Rest of Asia Pacific Therapeutics Market, By Molecule Type, By Value, 2020-2023 (USD Billion)

Table A52: Rest of Asia Pacific Therapeutics Market, By Molecule Type, By Value, 2025-2030 (USD Billion)

Table A53: Rest of Asia Pacific Therapeutics Market, By Therapeutic Area, By Value, 2020-2023 (USD Billion)

Table A54: Rest of Asia Pacific Therapeutics Market, By Therapeutic Area, By Value, 2025-2030 (USD Billion)

Table A55: Sanofi Key Financials, 2020-2022

Table A56: Cipla Key Financials, 2020-2022

Table A57: Pfizer Key Financials, 2021-2023

Table A58: GSK PLC Key Company Financials, 2020-2022

Table A59: Novartis Key Company Financials, 2020-2022

Table A60: Bayer AG Key Financials, 2020-2022

Table A61: Merck & Co., Inc. Key Financials, 2020-2022

Table A62: Roche Key Financials, 2021-2023

Table A63: Abbott Laboratories Key Financials, 2021-2023

Table A64: Gilead Sciences, Inc. Key Financials, 2021-2023